Back

Medscape, LLC

  • Antihypertensive Agents
  • Denervation
  • Hypertension

Integrating Long-Term Data and Clinical Guidelines for Renal Denervation in Hypertension Management

The goal of this activity is for learners to be better able to understand recent data on clinical trials for blood pressure (BP) control and the use of antihypertensive (AH) agents with renal denervation (RDN) to better achieve target BP rates in patients with hypertension and reduce hospitalizations due to hypertensive urgencies.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Aug 4, 2026
  • Last day to claim credit
    Aug 5, 2027 10 months left